{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/","result":{"pageContext":{"chapter":{"id":"576c0eda-301a-5d5f-9d9f-34505854cac8","slug":"palliative-cancer-care-malignant-skin-ulcer","fullItemName":"Scenario: Palliative cancer care - malignant skin ulcer","depth":2,"htmlHeader":"<!-- begin field 09f191b7-be90-4f1d-a05f-23a33a2c73e9 --><h2>Scenario: Palliative cancer care - malignant skin ulcer</h2><!-- end field 09f191b7-be90-4f1d-a05f-23a33a2c73e9 -->","summary":"Covers the management of malignant skin ulcers.","htmlStringContent":"<!-- begin item 0b0ba269-bc99-44ad-ac15-8eea6171193b --><!-- begin field 1966073d-aaaa-4b83-8754-acbc01588a97 --><p>From age 16 years onwards.</p><!-- end field 1966073d-aaaa-4b83-8754-acbc01588a97 --><!-- end item 0b0ba269-bc99-44ad-ac15-8eea6171193b -->","topic":{"id":"a66236f8-759a-578d-b8e0-d9b9f4d4b17b","topicId":"594ae15d-e8a6-49e1-9bc4-b8235684b211","topicName":"Palliative care - malignant skin ulcer","slug":"palliative-care-malignant-skin-ulcer","lastRevised":"Last revised in October 2018","chapters":[{"id":"8aae23f3-652c-5220-96a9-570f5c6a4197","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"3fae4ef2-1de8-537a-8d87-bb0f0e925ca2","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"7cd1b72b-f0ca-5fa9-a739-760c7315a4c6","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"28f3598f-1a0b-5fa6-885c-7908290eef3d","slug":"changes","fullItemName":"Changes"},{"id":"ee67bddb-c899-5cdf-8bd4-b6ce53a64863","slug":"update","fullItemName":"Update"}]},{"id":"7209a66f-e985-5a26-b178-2d841634478d","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"a512b109-ae33-58f1-9b3e-1bb25ba17ed1","slug":"goals","fullItemName":"Goals"},{"id":"d4f96da2-1dfd-5b18-aeec-d33fe0b56967","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"ec220b93-2051-5b93-ada7-66029759c688","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"e8a03776-8e6f-57f0-9d78-72e639758d72","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"a89f6107-4d65-56f2-a108-583acc3aa1dd","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"99d9f654-11a9-5749-882a-6bfac0a995ad","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"ba712e36-e31f-53bb-9746-10f4bb36e7e9","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"8ae192ef-3ead-55f6-b5dc-e15c6fbe8e92","slug":"definition","fullItemName":"Definition"},{"id":"6045e3e4-960f-5f2a-949e-66eaa7d7fd27","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"fb13b65f-08f4-5ac4-b21a-bbba9bec2bce","slug":"complications","fullItemName":"Complications"}]},{"id":"5750038d-2dca-5b1b-9cef-5ec97727cd6c","fullItemName":"Management","slug":"management","subChapters":[{"id":"576c0eda-301a-5d5f-9d9f-34505854cac8","slug":"palliative-cancer-care-malignant-skin-ulcer","fullItemName":"Scenario: Palliative cancer care - malignant skin ulcer"},{"id":"4c917ea3-8a66-5e50-9cd2-a4494533a824","slug":"end-of-life-care","fullItemName":"Scenario: End of life care"}]},{"id":"c6fd3a21-3f33-5f10-9f9b-22da77001d52","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"cce56ef7-baec-5a1f-9927-a88b697e0b79","slug":"metronidazole","fullItemName":"Metronidazole"}]},{"id":"6fb5a8ca-5e8b-5cea-9647-c8d15aa9fd31","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"c16178c4-497b-57f0-8903-94f79dc3e888","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"0676abc6-76ab-5fcf-816a-0f0fd3c08737","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"7c58ec18-ffff-5082-9660-ff776be47414","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"ec9b77b3-9f46-5d3d-89fe-1d2ba54e8e03","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"2b921fab-b857-5da1-90cd-616aa087e15a","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"f5f487fa-4ace-58e9-aefa-a01924f86557","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"0a5cfba7-db2d-58b1-b705-aef0029b384e","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"5750038d-2dca-5b1b-9cef-5ec97727cd6c","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"0494ea40-4ca9-503f-9898-1ef5206937ef","slug":"managing-a-malignant-skin-ulcer","fullItemName":"Managing a malignant skin ulcer","depth":3,"htmlHeader":"<!-- begin field 8af38206-5d8d-4d09-b669-e4c37e563359 --><h3>How should I manage a malignant skin ulcer?</h3><!-- end field 8af38206-5d8d-4d09-b669-e4c37e563359 -->","summary":null,"htmlStringContent":"<!-- begin item e1235e63-3cb1-466d-8f6b-a2ba17ed87e9 --><!-- begin field 24e53595-de65-406d-82a2-15708c87418e --><p><strong>Ensure a professional with expertise in wound management is involved in the person's care </strong>(such as a district nurse, palliative care or tissue viability nurse).</p><ul><li><strong>Discuss with the person:</strong><ul><li>Their treatment priorities and if possible, address these first.</li><li>Their concerns about the ulcer, and its impact on their daily functioning and quality of life.</li><li>That healing is unlikely to be a realistic goal, and explain that the aim is to maintain or improve their quality of life.</li></ul></li><li><strong>Assess the skin ulcer </strong><strong>for:</strong><ul><li>Its location, size, and whether it is <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/background-information/definition/\">ulcerative</a> or <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/background-information/definition/\">proliferative</a>, as these factors affect <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#dressing-choice-management\">dressing choice</a>.</li><li>The amount of necrotic tissue within the ulcer, as this affects the need for <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#wound-cleansing-debridement\">cleansing</a> or <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#wound-cleansing-debridement\">debridement</a>.</li><li>The condition of the surrounding skin, which may affect <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#dressing-choice-management\">dressing choice</a>, the method of securing the dressing, and the frequency of dressing changes.</li><li>Common complications such as <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#managing-pain\">pain</a>, <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#managing-infection\">infection</a>, <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#managing-bleeding\">bleeding</a>, <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#managing-exudate\">exudate</a>, <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#managing-odour\">odour</a>, <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#managing-itch\">itch</a>, and <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#psychosocial-issues\">psychosocial issues</a>.</li></ul></li><li><strong>Where appropriate, refer to an oncologist or palliative care specialist for advice if</strong>:<ul><li>Complications are present which may require specialist management (such as vessel compression or obstruction, airway obstruction, or the presence of significant necrotic tissue which might be suitable for larval therapy).</li><li>Further cancer treatment may be possible (such as radiotherapy, chemotherapy, hormone therapy, or surgery).</li></ul></li></ul><!-- end field 24e53595-de65-406d-82a2-15708c87418e --><!-- end item e1235e63-3cb1-466d-8f6b-a2ba17ed87e9 -->","subChapters":[{"id":"1f2f7f07-bfd2-5328-bef7-43aa952e01bf","slug":"wound-cleansing-debridement","fullItemName":"Wound cleansing and debridement","depth":4,"htmlHeader":"<!-- begin field 56595199-0618-4e61-97c2-22052fa8b567 --><h4>Wound cleansing and debridement</h4><!-- end field 56595199-0618-4e61-97c2-22052fa8b567 -->","summary":null,"htmlStringContent":"<!-- begin item 5992f81d-13f6-4952-816a-3b0913ab1b0b --><!-- begin field 9e237d92-9825-4bad-9d94-bc392cfa5177 --><p><strong>Ensure a professional with expertise in wound management </strong><strong>is involved in the person's care </strong>(such as a district, palliative care or tissue viability nurse).</p><ul><li><strong>Assessing whether ulcer cleansing is required.</strong><ul><li>Cleansing is useful for removing visible debris, excess slough, exudate, or any remaining dressing material.</li><li>Cleansing is advised prior to obtaining a microbiological swab (but do not take swabs unless there is clinical evidence of <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#managing-infection\">infection</a>).</li><li>Routine washing of wounds is unnecessary and undesirable.</li></ul></li><li><strong>Selecting the cleansing fluid</strong>.<ul><li>If a clean technique is being used, use warm tap or shower water.</li><li>If a sterile technique is required (for example where there is bony involvement or in a severely immunocompromized person), sterile 0.9% normal saline should be used.</li><li>Ideally the cleansing fluid should be at body temperature, or if this is not possible, the fluid should be warmed to room temperature before use.</li></ul></li><li><strong>Gently irrigating the ulcer and surrounding skin.</strong><ul><li>Do not clean wounds by scrubbing, which causes pain and local tissue oedema. Irrigation is more protective of fragile tissue.</li><li>Do not use cotton wool or gauze swabs as these shed fibres and increase the risk of infection.</li><li>Do not use topical antiseptics due to reported pain, tissue damage, wound drying, and delayed healing.</li></ul></li><li><strong>Reviewing whether debridement (removal of necrotic, devitalised, sloughy, or infected tissue) is appropriate.</strong><ul><li>Natural (autolytic) debridement may be promoted by the use of specialist dressings. For more information, see the section on <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#dressing-choice-management\">Dressing choice and management</a>.</li><li>Sharp debridement (using a sterile blade, scalpel, or scissors) is not recommended as it may cause bleeding in friable tissue. Specialist surgical debridement or sterile larval therapy may be appropriate following referral.</li><li>Mechanical debridement (removing necrotic tissue with gauze) is not recommended as it may indiscriminately remove granulation and epithelial tissue.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Wilson, 2005</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">McNees, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Leicester County and Rutland PCT, 2009</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Fernandez and Griffiths, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Tissue Viability Service, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">NHS Highland, 2013</a>].</p><!-- end field 9e237d92-9825-4bad-9d94-bc392cfa5177 --><!-- end item 5992f81d-13f6-4952-816a-3b0913ab1b0b -->","subChapters":[]},{"id":"b92bc75b-f8f8-539c-a533-c4f7bff34954","slug":"dressing-choice-management","fullItemName":"Dressing choice and management","depth":4,"htmlHeader":"<!-- begin field 4862936a-9a70-484e-90a5-8450aa925422 --><h4>Dressing choice and management</h4><!-- end field 4862936a-9a70-484e-90a5-8450aa925422 -->","summary":null,"htmlStringContent":"<!-- begin item d8b4b560-f8d1-49b3-bc0b-f6e0b19d39cd --><!-- begin field 053cbaac-7559-4031-a1b9-70e2e3888ee5 --><p><strong>Ensure a professional with expertise in wound management is involved in the person's care </strong>(such as a district, palliative care or tissue viability nurse).</p><ul><li><strong>The choice of dressing will depend on:</strong><ul><li><strong>The type, site, and size of the ulcer.</strong><ul><li>An appropriate size and type of dressing should be selected to avoid stretching or applying dressings under tension.</li></ul></li><li><strong>The presence of complications.</strong><ul><li>If there is <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#managing-pain\">pain</a> at dressing changes, non-adherent dressings should be used if possible, and dressings should be removed carefully (soak adherent dressings with normal saline before removal to minimize trauma).</li><li>If <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#managing-infection\">infection</a> is present, dressings with antimicrobial or antiseptic properties (for example silver, iodine, or medical-grade honey-impregnated dressings) may be considered. Some dressings can assist with natural (autolytic) debridement (for example hydrogels, hydrocolloids, foams, and alginates).</li><li>If <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#managing-bleeding\">bleeding</a> is present, non-adherent dressings should be used and dressings with haemostatic properties can be considered (for example alginate dressings, although they are not suitable for fragile wounds as they may cause bleeding on removal). Dressings should be removed carefully (soak adherent dressings with normal saline before removal to minimize trauma).</li><li>If <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#managing-exudate\">exudate</a> is present, dressings of appropriate absorbency should be used with secondary absorbent padding if required. Antimicrobial dressings may be useful if excess exudate is secondary to infection. If frequent dressing changes are needed, adhesive tape or dressings should be avoided.</li><li>If <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#managing-odour\">odour</a> is present, activated charcoal dressings may help absorb the smell, but they lose this ability once wet. This can mean that frequent dressing changes may be necessary and applied as a sealed unit. Dressings with antimicrobial or antiseptic properties (for example silver, iodine, or medical-grade honey-impregnated dressings) may be considered.</li></ul></li></ul></li><li><strong>Dressings should be changed as often as necessary to manage </strong><a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#managing-pain\">pain</a>, <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#managing-infection\">infection</a>, <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#managing-bleeding\">bleeding</a>, <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#managing-exudate\">exudate</a>, and <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#managing-odour\">odour</a>, but try to minimize changes where possible. If appropriate, people or their carers can be supported to change their own dressings.</li><li><strong>The area around the ulcer should be prepared </strong><strong>carefully to ensure a good seal.</strong><ul><li>If there is a risk of maceration (a change in appearance of skin resulting from prolonged exposure to moisture), protect the surrounding skin with a barrier cream or film. For more information, see the section on <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#managing-exudate\">Exudate</a>.</li><li>Alternative ways of securing dressings (such as netting or briefs) may be considered if the surrounding skin is damaged.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Fleck, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">McDonald and Lesage, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Nazarko, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Seaman, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Alvarez et al, 2007</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Grocott, 2007</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Langemo et al, 2007</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Lazelle-Ali, 2007</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Lee et al, 2007</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Hampton, 2008</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Stephen-Haynes, 2008</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Leicester County and Rutland PCT, 2009</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Da Costa Santos et al, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Regnard, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Tissue Viability Service, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">NHS Highland, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">BNF 72, 2016</a>].</p><!-- end field 053cbaac-7559-4031-a1b9-70e2e3888ee5 --><!-- end item d8b4b560-f8d1-49b3-bc0b-f6e0b19d39cd -->","subChapters":[]},{"id":"6a3f2c08-a329-5c7c-a604-db0aace383e7","slug":"basis-for-recommendation-a59","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field fd4618c7-0d36-484e-b605-f1597f8a643f --><h4>Basis for recommendation</h4><!-- end field fd4618c7-0d36-484e-b605-f1597f8a643f -->","summary":null,"htmlStringContent":"<!-- begin item a59e7ca7-107e-44c1-bed6-9d45dd1d7e36 --><!-- begin field bdc134b2-552a-4608-9e27-7845f58af120 --><h5>Discussing aims of treatment</h5><ul><li>The recommendations regarding discussion with the person are based on expert opinion in a narrative review [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Nazarko, 2006</a>] and the textbook, <em>Symptom management in advanced cancer </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Twycross et al, 2009</a>].</li></ul><h5>Assessment of the skin ulcer</h5><ul><li>The recommendations on wound assessment are based on expert opinion in narrative reviews [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Grey et al, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">McDonald and Lesage, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Nazarko, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Seaman, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Paul and Pieper, 2008</a>].</li></ul><h5>Referral to an oncologist or palliative care specialist</h5><ul><li>The recommendations to refer people with complications such as the presence of significant necrotic tissue is based on expert opinion in the textbook, <em>A guide to symptom relief in palliative care </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Regnard, 2010</a>], which states that larval therapy may help with debridement.</li><li>The recommendation to refer to an oncologist or palliative care specialist for advice regarding any further treatment of the underlying cancer is based on expert opinion in the textbooks, <em>Symptom management in advanced cancer </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Twycross et al, 2009</a>] and <em>A guide to symptom relief in palliative care </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Regnard, 2010</a>].</li></ul><!-- end field bdc134b2-552a-4608-9e27-7845f58af120 --><!-- end item a59e7ca7-107e-44c1-bed6-9d45dd1d7e36 -->","subChapters":[]}]},{"id":"df6c4bd0-1962-5375-9881-40a8fd7451b0","slug":"managing-pain","fullItemName":"Managing pain","depth":3,"htmlHeader":"<!-- begin field 879d57fe-afbf-4ae0-8453-e4e6abff85f2 --><h3>How should I manage pain?</h3><!-- end field 879d57fe-afbf-4ae0-8453-e4e6abff85f2 -->","summary":null,"htmlStringContent":"<!-- begin item 7ff98295-cc2b-41c2-90e2-9be58456bf1b --><!-- begin field 8d65e542-d694-4747-adf9-ce6674fe79e0 --><ul><li><strong>Identify and manage the cause of pain where possible, </strong>for example the presence of infection, surrounding skin irritation, or dressing changes.<ul><li>Pain can last an hour or more after a dressing change.</li></ul></li><li><strong>Prescribe analgesia if needed. </strong>For information on pain management, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/palliative-cancer-care-pain/\">Palliative cancer care - pain</a>.<ul><li>A topical local anaesthetic should only be used on the advice of a specialist.</li></ul></li><li><strong>If there is pain at dressing changes:</strong><ul><li>Ensure a person with expertise in wound management is involved in the person's care (such as a district, palliative or tissue viability nurse) to select an <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#dressing-choice-management\">appropriate dressing&nbsp;</a> and where possible, ensure the frequency of dressing changes is minimized.</li><li>Ensure administration of a breakthrough dose of analgesia at least 30 minutes before a dressing change where possible. For more information, see the section on the <a class=\"topic-reference external-reference\" href=\"/topics/palliative-cancer-care-pain/management/managing-pain-non-emergency/#management-of-breakthrough-pain\">Management of breakthrough pain </a> in the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/palliative-cancer-care-pain/\">Palliative cancer care - pain</a>.</li></ul></li></ul><!-- end field 8d65e542-d694-4747-adf9-ce6674fe79e0 --><!-- end item 7ff98295-cc2b-41c2-90e2-9be58456bf1b -->","subChapters":[{"id":"0cf658c3-a500-54c9-ad05-66739803b8e5","slug":"basis-for-recommendation-f7f","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field ae43e698-a53b-438c-9e6a-b2f92a5c5e45 --><h4>Basis for recommendation</h4><!-- end field ae43e698-a53b-438c-9e6a-b2f92a5c5e45 -->","summary":null,"htmlStringContent":"<!-- begin item f7f769b5-81cb-4360-8dd7-ac7232149d40 --><!-- begin field 41780c98-be0a-4a33-a8f2-4742cfa881c2 --><h5>Identifying and managing the cause of pain</h5><ul><li>The recommendation to identify and manage the cause of pain is based on expert opinion in a narrative review [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Grey et al, 2006</a>].</li><li>Information that pain can last an hour of more after a dressing change is based on expert opinion in the National Pressure Ulcer Advisory Panel consensus guideline, <em>Pressure ulcers in individuals receiving palliative care </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Langemo et al, 2010</a>].</li></ul><h5>Prescribing analgesia if needed</h5><ul><li>The recommendation that a topical local anaesthetic should only be used on the advice of a specialist is based on expert opinion in a narrative review which stated that topical anaesthesia can increase inflammation which may increase the risk of infection [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">McDonald and Lesage, 2006</a>].</li></ul><h5>Managing pain at dressing changes</h5><ul><li>The recommendation regarding dressing choice and frequency of changes is based on expert opinion in narrative reviews [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">McDonald and Lesage, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Seaman, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Alvarez et al, 2007</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Lazelle-Ali, 2007</a>], expert consensus in a regional primary care guideline, <em>Policy for the management of fungating wounds </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Leicester County and Rutland PCT, 2009</a>], and the textbook,  <em>A guide to symptom relief in palliative care </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Regnard, 2010</a>].</li><li>The recommendation to give a breakthrough dose of analgesia before a dressing change is based on expert opinion in narrative reviews [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">McDonald and Lesage, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Seaman, 2006</a>], expert consensus in a regional primary care guideline, <em>Policy for the management of fungating wounds </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Leicester County and Rutland PCT, 2009</a>], the textbook <em>A guide to symptom relief in palliative care </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Regnard, 2010</a>], and expert opinion in the National Pressure Ulcer Advisory Panel consensus guideline, <em>Pressure ulcers in individuals receiving palliative care </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Langemo et al, 2010</a>].</li></ul><!-- end field 41780c98-be0a-4a33-a8f2-4742cfa881c2 --><!-- end item f7f769b5-81cb-4360-8dd7-ac7232149d40 -->","subChapters":[]}]},{"id":"2e77f72b-9590-5236-8a91-c5d5030dd507","slug":"managing-infection","fullItemName":"Managing infection","depth":3,"htmlHeader":"<!-- begin field 7c8d6cec-7807-4d5c-b0d2-ad425b1a3f8d --><h3>How should I manage suspected infection?</h3><!-- end field 7c8d6cec-7807-4d5c-b0d2-ad425b1a3f8d -->","summary":null,"htmlStringContent":"<!-- begin item 30d86458-5f2d-49eb-a747-288e481c087f --><!-- begin field f57e5b35-ff70-4706-b730-e0c847ffe666 --><ul><li><strong>Make a diagnosis of infection based on clinical symptoms and signs. Check for:</strong><ul><li>Fever or malaise.</li><li>Wound breakdown, abscess, or cellulitis.</li><li>Increased or altered appearance of <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#managing-exudate\">exudate</a>, increased <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#managing-pain\">pain</a> at the site, or the presence of <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#managing-odour\">odour</a>.</li></ul></li><li><strong>If infection is suspected, <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#wound-cleansing-debridement\">cleanse</a> the surface, then take a swab</strong>.<ul><li>Cleanse the area using sterile water or 0.9% saline, then run the tip of the swab across the wound in a 'zig zag' manner and at the same time rotate the swab handle.</li><li>Use clinical judgement when interpreting a swab result, as the presence of bacteria does not always indicate that a wound is infected.</li></ul></li><li><strong>Assess whether ulcer <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#wound-cleansing-debridement\">debridement</a> (removal of necrotic, devitalised, sloughy or infected tissue) is appropriate.</strong><ul><li>Natural (autolytic) debridement may be promoted by the use of <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#dressing-choice-management\">specialist dressings</a>.</li><li>Specialist referral for surgical debridement or sterile larval therapy may be appropriate.</li></ul></li><li><strong>Ensure an <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#dressing-choice-management\">appropriate dressing</a></strong> <strong>i</strong><strong><strong>s</strong> used with an optimum frequency of dressing change.</strong></li><li><strong>If an antibiotic is indicated due to suspected infection or surrounding <a class=\"topic-reference external-reference\" href=\"/topics/cellulitis-acute/\">Cellulitis</a>, </strong>see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/cellulitis-acute/\">Cellulitis - acute</a> for more information on the choice of antibiotic.<ul><li>Review the choice of antibiotic once the swab result is available.</li></ul></li><li><strong>If an antibiotic is indicated for odour, </strong>see the section on <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#managing-odour\">managing odour</a>.</li></ul><!-- end field f57e5b35-ff70-4706-b730-e0c847ffe666 --><!-- end item 30d86458-5f2d-49eb-a747-288e481c087f -->","subChapters":[{"id":"976af6ec-64c8-5b4c-99dc-84e51c7f84c0","slug":"basis-for-recommendation-735","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 7c9c6c4a-c318-47eb-aba8-d5685593a92b --><h4>Basis for recommendation</h4><!-- end field 7c9c6c4a-c318-47eb-aba8-d5685593a92b -->","summary":null,"htmlStringContent":"<!-- begin item 7355cbfc-27f8-4537-9325-f4ac17838048 --><!-- begin field 39d8c562-d26a-4874-809e-c1bef17a9fa2 --><h5>Clinical diagnosis of infection</h5><ul><li>The information that the diagnosis of infection is based on clinical symptoms and signs is taken from expert opinion in a narrative review [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">McDonald and Lesage, 2006</a>], the expert consensus regional guideline, <em>Wound management clinical practice guidelines </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Tissue Viability Service, 2012</a>], an expert consensus regional guideline<em>, NHS Highland wound management guidelines and formulary </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">NHS Highland, 2013</a>], which states that the most sensitive indicators of infection are increasing pain and wound breakdown.</li></ul><h5>Taking a swab</h5><ul><li>The recommendation for the technique of taking a swab and interpreting the results is taken from the expert consensus regional guideline, <em>Wound management clinical practice guidelines </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Tissue Viability Service, 2012</a>], and an expert consensus regional guideline,<em>NHS Highland wound management guidelines and formulary </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">NHS Highland, 2013</a>].</li></ul><h5>Considering debridement</h5><ul><li>The recommendations regarding debridement methods are taken from expert opinion in a narrative review [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Nazarko, 2006</a>], expert consensus in a regional primary care guideline, <em>Policy for the management of fungating wounds </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Leicester County and Rutland PCT, 2009</a>], and an expert consensus regional guideline <em>Wound Management Clinical Practice Guidelines </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Tissue Viability Service, 2012</a>].</li></ul><!-- end field 39d8c562-d26a-4874-809e-c1bef17a9fa2 --><!-- end item 7355cbfc-27f8-4537-9325-f4ac17838048 -->","subChapters":[]}]},{"id":"e0179d1b-737e-5bd7-b0f2-5507f5c2d501","slug":"managing-bleeding","fullItemName":"Managing bleeding","depth":3,"htmlHeader":"<!-- begin field 8c899e16-c01f-49be-abaa-6c90f397e9c6 --><h3>How should I manage bleeding?</h3><!-- end field 8c899e16-c01f-49be-abaa-6c90f397e9c6 -->","summary":null,"htmlStringContent":"<!-- begin item 00186a56-9ec5-48d7-a58e-a99140f4b504 --><!-- begin field 52c07c9b-170c-413c-b30a-ee15add5e0b5 --><ul><li><strong>If there is acute bleeding from a definite point in the ulcer, </strong>assess the severity of bleeding:<ul><li><strong>For mild bleeding, </strong>apply gentle pressure for 10–15 minutes with a moist, non-adherent dressing. Avoid causing unnecessary pain.</li><li><strong>For heavier bleeding, </strong>apply pressure and seek urgent advice from the person's oncologist or palliative care team. Admission may be appropriate depending on the stage of illness.<ul><li>Anti-fibrinolytic treatment (for example tranexamic acid) may be useful, but should only be prescribed on specialist advice.</li><li>Other options which may be available in a specialist setting include haemostatic foams or sponges, sucralfate paste, radiotherapy, embolization, and cautery.</li></ul></li><li><strong>For severe bleeding at the end of life, </strong>use dark towels to absorb blood to minimize distress to the person and their family, and consider sedation with a benzodiazepine. For more information on prescribing, see the section on <a class=\"topic-reference external-reference\" href=\"/topics/palliative-care-dyspnoea/prescribing-information/benzodiazepines/\">Benzodiazepines</a> in the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/palliative-care-dyspnoea/\">Palliative care - dyspnoea</a>.</li></ul></li><li><strong>Ensure that the risk of bleeding is minimized with appropriate <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#dressing-choice-management\">dressing choice</a>.</strong></li><li><strong>Review and consider stopping drugs which may contribute to bleeding, </strong>for example oral anticoagulants (such as warfarin), depending on clinical judgement and the stage of the illness.</li><li><strong>Consider checking the person's full blood count and coagulation.</strong></li></ul><!-- end field 52c07c9b-170c-413c-b30a-ee15add5e0b5 --><!-- end item 00186a56-9ec5-48d7-a58e-a99140f4b504 -->","subChapters":[{"id":"76ec2da4-ab45-5d9f-8699-f8d5f66f570b","slug":"basis-for-recommendation-8f9","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 79a73f61-2850-46ae-a35b-1dd489ab7e8e --><h4>Basis for recommendation</h4><!-- end field 79a73f61-2850-46ae-a35b-1dd489ab7e8e -->","summary":null,"htmlStringContent":"<!-- begin item 8f9c25ec-119b-4f31-93e3-9ee6e0dceea0 --><!-- begin field 245bb41e-97ec-4a36-951f-515430212330 --><h5>Managing acute bleeding</h5><ul><li>The recommendations on how to manage acute bleeding are based on expert opinion in narrative reviews [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">McDonald and Lesage, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Nazarko, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Seaman, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Alvarez et al, 2007</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Grocott, 2007</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Langemo et al, 2007</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Lazelle-Ali, 2007</a>] and an expert consensus regional primary care guideline, <em>Guidelines for the management of fungating wounds </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Leicester County and Rutland PCT, 2009</a>].</li></ul><h5>Minimizing the risk of bleeding with appropriate dressing choice and use</h5><ul><li>This recommendation is based on expert opinion in narrative reviews [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">McDonald and Lesage, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Nazarko, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Seaman, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Alvarez et al, 2007</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Grocott, 2007</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Lazelle-Ali, 2007</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Stephen-Haynes, 2008</a>] and an expert consensus regional primary care guideline, <em>Guidelines for the management of fungating wounds </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Leicester County and Rutland PCT, 2009</a>].</li></ul><h5>Reviewing drugs</h5><ul><li>This recommendation is based on expert opinion in the textbook, <em>A guide to symptom relief in palliative care </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Regnard, 2010</a>].</li></ul><h5>Considering checking full blood count and coagulation</h5><ul><li>The recommendation to consider checking a full blood count is based on expert opinion in a narrative review [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Nazarko, 2006</a>], and the recommendation to consider checking coagulation is based on information in narrative reviews that there may be decreased platelet function due to the presence of a malignancy [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Langemo et al, 2007</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Stephen-Haynes, 2008</a>].</li></ul><!-- end field 245bb41e-97ec-4a36-951f-515430212330 --><!-- end item 8f9c25ec-119b-4f31-93e3-9ee6e0dceea0 -->","subChapters":[]}]},{"id":"bce93f28-82b6-54b1-9921-4bf994076f89","slug":"managing-exudate","fullItemName":"Managing exudate","depth":3,"htmlHeader":"<!-- begin field f05e1e1a-c2af-4f20-aeba-2a2e92ab1baf --><h3>How should I manage exudate?</h3><!-- end field f05e1e1a-c2af-4f20-aeba-2a2e92ab1baf -->","summary":null,"htmlStringContent":"<!-- begin item e8df6d64-3672-47c0-a679-cd4034d371dd --><!-- begin field 5a441c5d-b5fe-4865-b728-5515e1f95d30 --><ul><li><strong>Assess the volume and appearance of the exudate as changes may indicate the presence of <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#managing-infection\">infection</a>.</strong><ul><li>Volume can be assessed as none (dry), scant, small, moderate, and copious.</li><li>Appearance can be described as serous, fibrinous, purulent, haemopurulent, or haemorrhagic.</li></ul></li><li><strong>Ensure the area is <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#wound-cleansing-debridement\">cleansed</a></strong> to clear visible debris, excess slough, and exudate.</li><li><strong>Assess whether <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#wound-cleansing-debridement\">ulcer debridement</a></strong> <strong>(r</strong><strong>emoval of necrotic, devitalised, sloughy or infected tissue) is appropriate.</strong><ul><li>Natural (autolytic) debridement may be promoted by the use of <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#wound-cleansing-debridement\">specialist dressings</a>.</li><li>Specialist referral for surgical debridement or sterile larval therapy may be appropriate.</li></ul></li><li><strong>Ensure an <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#dressing-choice-management\">appropriate dressing</a></strong> <strong>i</strong><strong><strong>s</strong> used with an optimum frequency of dressing change.</strong></li><li><strong>Ensure the surrounding skin is protected.</strong><ul><li>Consider using a barrier cream (for example zinc or dimeticone) or film to prevent maceration.</li><li>Consider prescribing a topical steroid, such as 1% hydrocortisone cream, to reduce surrounding skin inflammation. For prescribing information, see the <a class=\"topic-reference external-reference\" href=\"/topics/corticosteroids-topical-skin-nose-eyes/management/topical-treatment/\">Scenario: Topical treatment&nbsp;</a> in the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/corticosteroids-topical-skin-nose-eyes/\">Corticosteroids - topical (skin), nose, and eyes</a>.</li><li>Alternative ways of securing dressings (such as netting or briefs) may be considered if the surrounding skin is damaged.</li></ul></li><li><strong>If there is copious exudate:</strong><ul><li>Seek specialist advice (for example from the person's oncologist, palliative care team, or tissue viability nurse), as additional treatments (for example radiotherapy, use of a stoma appliance or collection pouch) may be helpful.</li></ul></li><li><strong>Consider referral to a dietitian for nutritional support</strong>, as significant amounts of protein can be lost from a discharging wound.</li></ul><!-- end field 5a441c5d-b5fe-4865-b728-5515e1f95d30 --><!-- end item e8df6d64-3672-47c0-a679-cd4034d371dd -->","subChapters":[{"id":"e61648f8-0566-5779-a36a-0bbfa99a8e2c","slug":"basis-for-recommendation-f98","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 9e5a9418-91f0-4729-90f5-9fa16368177e --><h4>Basis for recommendation</h4><!-- end field 9e5a9418-91f0-4729-90f5-9fa16368177e -->","summary":null,"htmlStringContent":"<!-- begin item f9881bfc-95fd-4908-9758-8888be82260c --><!-- begin field 343cc98f-0d70-4c4a-ae58-290ffe7d5f4f --><h5>Assessing the volume and appearance of exudate</h5><ul><li>The recommendation to classify an exudate by volume and appearance is based on an expert consensus regional guideline<em>, NHS Highland wound management guidelines and formulary </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">NHS Highland, 2013</a>] as changes in exudate may indicate the presence of infection.</li></ul><h5>Wound cleansing</h5><ul><li>The recommendation to cleanse the wound in the presence of exudate is based on an expert consensus regional primary care guideline, <em>Policy for the </em><em>management of fungating wounds </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Leicester County and Rutland PCT, 2009</a>], evidence from a Cochrane systematic review, <em>Water for wound cleansing </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Fernandez and Griffiths, 2012</a>], the expert consensus regional guideline <em>Wound Management Clinical Practice Guidelines </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Tissue Viability Service, 2012</a>], and the expert consensus regional guideline <em>NHS Highland wound management guidelines and formulary </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">NHS Highland, 2013</a>].</li></ul><h5>Considering debridement</h5><ul><li>The recommendations regarding debridement methods are taken from expert opinion in a narrative review [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Nazarko, 2006</a>], expert consensus in a regional primary care guideline,<em>Policy for the management of fungating wounds </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Leicester County and Rutland PCT, 2009</a>], and an expert consensus regional guideline <em>Wound Management Clinical Practice Guidelines </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Tissue Viability Service, 2012</a>].</li></ul><h5>Use and choice of dressings</h5><ul><li>Recommendations regarding the choice and use of dressings are based on expert opinion in narrative reviews [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">McDonald and Lesage, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Nazarko, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Seaman, 2006</a>]; [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Alvarez et al, 2007</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Grocott, 2007</a>], an expert consensus regional primary care guideline, <em>Policy for the management of fungating wounds </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Leicester County and Rutland PCT, 2009</a>], and an expert consensus regional guideline,<em>NHS Highland wound management guidelines and formulary </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">NHS Highland, 2013</a>].</li></ul><h5>Protecting the surrounding skin</h5><ul><li>This recommendation is based on expert opinion in narrative reviews [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">McDonald and Lesage, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Nazarko, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Seaman, 2006</a>]; [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Langemo et al, 2007</a>]; [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Stephen-Haynes, 2008</a>], an expert consensus regional guideline, <em>NHS Highland wound management guidelines and formulary </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">NHS Highland, 2013</a>], and opinion from previous external reviewers of this CKS topic.</li></ul><h5>Management of copious exudate</h5><ul><li>The recommendation to seek specialist advice for possible additional treatments is based on expert opinion in narrative reviews [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">McDonald and Lesage, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Nazarko, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Seaman, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Alvarez et al, 2007</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Benbow, 2008</a>], and in the textbook <em>A guide to symptom relief in palliative care </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Regnard, 2010</a>].</li></ul><h5>Referral to a dietitian</h5><ul><li>The recommendation to refer to a dietician is based on the expert consensus regional primary care guideline, <em>Policy for the management of fungating wounds </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Leicester County and Rutland PCT, 2009</a>]], the expert consensus regional guideline <em>Wound Management Clinical Practice Guidelines </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Tissue Viability Service, 2012</a>], and the expert consensus regional guideline <em>NHS Highland wound management guidelines and formulary </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">NHS Highland, 2013</a>].</li></ul><!-- end field 343cc98f-0d70-4c4a-ae58-290ffe7d5f4f --><!-- end item f9881bfc-95fd-4908-9758-8888be82260c -->","subChapters":[]}]},{"id":"d48fda21-df16-5c9a-9834-5e333b9e0863","slug":"managing-odour","fullItemName":"Managing odour","depth":3,"htmlHeader":"<!-- begin field 5313757e-f469-4cec-90c3-bac603bee94f --><h3>How should I manage odour?</h3><!-- end field 5313757e-f469-4cec-90c3-bac603bee94f -->","summary":null,"htmlStringContent":"<!-- begin item 1629adf7-9b31-4ea2-8030-73fc18228752 --><!-- begin field 07061a59-5c7d-4475-8790-e26f4e65a10b --><ul><li><strong>Ensure an <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#dressing-choice-management\">appropriate dressing</a></strong> <strong>i</strong><strong><strong>s</strong> used with an optimum frequency of dressing change.</strong></li><li><strong>Prescribe topical or oral metronidazole if the<strong> <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#dressing-choice-management\">appropriate dressings</a></strong></strong> <strong>d</strong><strong><strong>o</strong> not control odour.</strong><ul><li>Topical metronidazole (0.75%) is more effective if there is excess necrotic tissue present.<ul><li>It is not suitable for wounds with significant exudate, as it may be 'washed off' the wound surface.</li><li>Advise that it should be applied liberally to the ulcer once or twice a day for 7 days. If there is a partial response, consider continuing treatment for a further 7 days.</li><li>For further information on the use of topical metronidazole see the <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/prescribing-information/metronidazole/\">Prescribing information</a> section.</li></ul></li><li>Oral metronidazole may be better for deep tissue infections causing odour.<ul><li>Prescribe 400 mg three times a day, for 5–7 days. If there is a partial response, consider continuing treatment for a further 7 days.</li><li>For further information on the use of oral metronidazole see the <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/prescribing-information/metronidazole/\">Prescribing information</a> section.</li></ul></li><li><strong>If odour recurs after a course of metronidazole, repeat another 14-day course of topical or oral treatment.</strong><ul><li>If odour recurs after intermittent treatment with metronidazole, continue treatment with metronidazole long-term, either topically (once or twice a day at dressing changes) or orally 200 mg twice a day (off-label use).</li><li>For further information on the use of metronidazole see the <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/prescribing-information/metronidazole/\">Prescribing information</a> section.</li></ul></li></ul></li><li><strong>Consider seeking specialist advice from the person's oncologist or palliative care team, </strong>as treatments such as silver dressings, sugar paste, iodine, or medical-grade honey-impregnated dressings may be helpful.</li><li><strong>Consider additional measures to modify the person's environment </strong>to reduce odour, after discussion with the person, family, and/or carers. These include:<ul><li>Room scents (for example vanilla or coffee), although strong scents may induce nausea.</li><li>External odour absorbers (for example a tray of cat litter or activated charcoal under the bed).</li></ul></li></ul><!-- end field 07061a59-5c7d-4475-8790-e26f4e65a10b --><!-- end item 1629adf7-9b31-4ea2-8030-73fc18228752 -->","subChapters":[{"id":"d89034bb-4c44-5d54-917e-05488d069974","slug":"basis-for-recommendation-245","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 3f457a8f-4029-4dd0-8a9f-050f956fc1ec --><h4>Basis for recommendation</h4><!-- end field 3f457a8f-4029-4dd0-8a9f-050f956fc1ec -->","summary":null,"htmlStringContent":"<!-- begin item 24568296-7a9d-4b08-b3fe-c81d0163e184 --><!-- begin field 5fb0e7da-09e1-467b-85f7-1f832d4fc450 --><h5>Topical metronidazole</h5><ul><li>There is limited evidence from small trials that topical metronidazole is effective for reducing odour [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Finlay et al, 1996</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Kuge et al, 1996</a>]; [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Bale et al, 2004</a>]; [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Kalinski et al, 2005</a>]. A later systematic review of the use of topical metronidazole (used on average once a day for 14 consecutive days) found it helpful in reducing odour [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Da Costa Santos et al, 2010</a>].</li><li>The recommendation to use topical metronidazole to treat odour is also based on expert opinion in narrative reviews [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Wilson, 2005</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Fleck, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">McDonald and Lesage, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Alvarez et al, 2007</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Langemo et al, 2007</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Nazarko, 2007</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Lazelle-Ali, 2007</a>], and expert opinion in the National Pressure Ulcer Advisory Panel consensus guideline, <em>Pressure ulcers in individuals receiving palliative care </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Langemo et al, 2010</a>].</li><li>The recommendation that topical metronidazole may be useful for people with excess necrotic tissue is based on the information that antibiotics delivered systemically do not reach the wound bed in therapeutic levels in the presence of slough or necrotic tissue [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Paul and Pieper, 2008</a>].</li><li>The recommendation that topical metronidazole is unsuitable for wounds with significant exudate as topical metronidazole may be 'washed off' the wound surface is based on expert opinion in narrative reviews [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Nazarko, 2006</a>]; [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Lazelle-Ali, 2007</a>].</li></ul><h5>Oral metronidazole</h5><ul><li>There is limited evidence from small trials and case series that oral metronidazole is effective at reducing odour [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Sparrow et al, 1980</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Dankert et al, 1981</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Ashford et al, 1984</a>].</li><li>The recommendation to use oral metronidazole to treat odour is also based on expert opinion in narrative reviews [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Wilson, 2005</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">McDonald and Lesage, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Nazarko, 2007</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Paul and Pieper, 2008</a>].</li><li>The recommendation that oral metronidazole may also be a more appropriate choice if there is evidence of deep tissue infection is based on expert opinion in a narrative review [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">McDonald and Lesage, 2006</a>].</li><li>The recommended dose and duration of oral metronidazole varies in the literature.<ul><li>Expert opinion in a textbook <em>Symptom management in advanced cancer </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Twycross et al, 2009</a>] recommends 400 mg three times daily for 5 days.</li><li>Expert opinion in a textbook <em>A guide to symptom relief in palliative care </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Regnard, 2010</a>] recommends 400 mg three times daily for 5 days, continuing with 400–500 mg once daily but did not specify a duration of treatment.</li><li>Expert opinion in a review article <em>Assessment and management of fungating wounds: a review</em>, [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Wilson, 2005</a>], advises 400 mg three times daily for 14 days or 200 mg twice daily for people who are elderly, frail, or debilitated.</li></ul></li></ul><h5>Repeating treatment with metronidazole</h5><ul><li>The recommendation that repeat treatment may be required with topical metronidazole is based on expert opinion in a narrative review [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">McDonald and Lesage, 2006</a>].</li><li>The recommendation regarding a repeat course of oral metronidazole for recurrent symptoms is pragmatic, based on what CKS considers reasonable clinical practice.</li></ul><h5>Long-term treatment with topical or oral metronidazole</h5><ul><li>The recommendation regarding the use of long-term metronidazole gel is based on expert opinion in a narrative review which states that in one report, topical metronidazole was used for up to 15 months [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Paul and Pieper, 2008</a>].</li><li>The recommendation regarding the use of long-term oral metronidazole is based on expert opinion in a narrative review which states that if malodour recurs, maintenance treatment with 200 mg twice a day should be considered [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Wilson, 2005</a>], and expert opinion in a textbook <em>A guide to symptom relief in palliative care </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Regnard, 2010</a>], which recommends treatment with 400 mg three times daily for 5 days, continuing with 400–500 mg once daily, full duration not specified.</li></ul><h5>Seeking specialist advice</h5><ul><li>The recommendation to seek specialist advice for additional treatments is based on expert opinion in narrative reviews [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Fleck, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">McDonald and Lesage, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Nazarko, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Grocott, 2007</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">McManus, 2007</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Hampton, 2008</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Paul and Pieper, 2008</a>].</li><li>The use of silver dressings to minimize odour proved contentious among previous external reviewers of this CKS topic but is recommended in narrative reviews [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">McManus, 2007</a>]; [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Hampton, 2008</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Langemo et al, 2010</a>].</li></ul><h5>Additional environmental measures</h5><ul><li>The recommendation to consider room scents or external odour absorbers is based on expert opinion in narrative reviews [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Nazarko, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Seaman, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Langemo et al, 2007</a>]. Opinion varies on whether these measures are effective or whether they may stimulate nausea, and is discussed further in narrative reviews [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">McDonald and Lesage, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Paul and Pieper, 2008</a>].</li></ul><!-- end field 5fb0e7da-09e1-467b-85f7-1f832d4fc450 --><!-- end item 24568296-7a9d-4b08-b3fe-c81d0163e184 -->","subChapters":[]}]},{"id":"d84315c4-2e99-5aa4-92e0-a6f44d27aadf","slug":"managing-itch","fullItemName":"Managing itch","depth":3,"htmlHeader":"<!-- begin field 8329c12c-0f46-4bac-bb0e-97bcac1d5ca4 --><h3>How should I manage itch?</h3><!-- end field 8329c12c-0f46-4bac-bb0e-97bcac1d5ca4 -->","summary":null,"htmlStringContent":"<!-- begin item 05a4f8ae-fe76-4f4b-b559-3d34dbe7e2a0 --><!-- begin field 95125bfa-93d1-4a2b-9370-6a6927fb4196 --><ul><li><strong>Consider the use of a mild topical corticosteroid </strong>such as 1% hydrocortisone cream if the skin around the ulcer is red and scaly.<ul><li>Exclude other causes of irritation, such as a local infection or irritation from dressings or treatments applied to the area.</li><li>For more information on the use of topical corticosteroids, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/corticosteroids-topical-skin-nose-eyes/\">Corticosteroids - topical (skin), nose, and eyes</a>.</li></ul></li><li><strong>If the itch remains problematic, seek specialist advice </strong>from the person's palliative care team, as it may be difficult to treat.<ul><li>Transcutaneous electrical nerve stimulation (TENS) may be considered in a specialist setting.</li></ul></li></ul><!-- end field 95125bfa-93d1-4a2b-9370-6a6927fb4196 --><!-- end item 05a4f8ae-fe76-4f4b-b559-3d34dbe7e2a0 -->","subChapters":[{"id":"b48be730-2a69-5a0f-a408-9ad72663360c","slug":"basis-for-recommendation-892","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field dd8e6bb5-7132-4a1d-a0e7-3c3e4a6fcbf1 --><h4>Basis for recommendation</h4><!-- end field dd8e6bb5-7132-4a1d-a0e7-3c3e4a6fcbf1 -->","summary":null,"htmlStringContent":"<!-- begin item 8929c91c-aeed-4114-be0d-2a927d428673 --><!-- begin field 76063659-e668-40aa-9556-743a0b01a878 --><h5>Using a topical corticosteroid</h5><ul><li>Expert opinion from previous external reviewers of this CKS topic varied on whether topical corticosteroids should be used for the itch associated with malignant ulcers, and the appropriate potency and duration of use. This recommendation is therefore pragmatic, based on what CKS considers to be good clinical practice. The use of a corticosteroid to relieve itch is recommended by expert opinion in the textbook, <em>A guide to symptom relief in palliative care </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Regnard, 2010</a>].</li></ul><h5>Seeking specialist advice</h5><ul><li>The recommendation to consider seeking specialist advice on the use of transcutaneous electrical nerve stimulation (TENS) is based on expert opinion in narrative reviews [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">McDonald and Lesage, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Grocott, 2007</a>], and expert opinion in the textbook, <em>A guide to symptom relief in palliative care </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Regnard, 2010</a>].</li></ul><!-- end field 76063659-e668-40aa-9556-743a0b01a878 --><!-- end item 8929c91c-aeed-4114-be0d-2a927d428673 -->","subChapters":[]}]},{"id":"ae4149c5-085d-50da-91c1-66161cf18b85","slug":"psychosocial-issues","fullItemName":"Psychosocial issues","depth":3,"htmlHeader":"<!-- begin field 9f43c093-56e4-4c10-835f-5196a3e67114 --><h3>How should I manage psychosocial issues?</h3><!-- end field 9f43c093-56e4-4c10-835f-5196a3e67114 -->","summary":null,"htmlStringContent":"<!-- begin item abcf3137-b5a0-44b1-88e0-55a1eff5f837 --><!-- begin field de525a1b-3d6a-445b-a3c4-74275e4924f2 --><ul><li><strong>Manage <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#managing-exudate\">exudate</a> and <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/management/palliative-cancer-care-malignant-skin-ulcer/#managing-odour\">odour</a> as effectively as possible.</strong><ul><li>Odour is often the most distressing complication for the person, their family, and carers.</li></ul></li><li><strong>Aim for a good cosmetic effect with dressings, </strong>for example:<ul><li>Use dressings to fill any defect (for example a cavity in an ulcer).</li><li>Ensure dressings protect clothing.</li><li>Use a less bulky dressing material if the person is going out (this may mean using a less absorbent dressing).</li></ul></li><li>For more information on the social, psychological, and spiritual aspects of palliative care, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/palliative-care-general-issues/\">Palliative care - general issues</a>.</li></ul><!-- end field de525a1b-3d6a-445b-a3c4-74275e4924f2 --><!-- end item abcf3137-b5a0-44b1-88e0-55a1eff5f837 -->","subChapters":[{"id":"4d19d1cb-ed3b-50cd-9871-c41d8fe5c058","slug":"basis-for-recommendation-78c","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 46375910-5c4c-447b-b4f2-7fc2d59a70ee --><h4>Basis for recommendation</h4><!-- end field 46375910-5c4c-447b-b4f2-7fc2d59a70ee -->","summary":null,"htmlStringContent":"<!-- begin item 78c586f4-bc9e-4e22-8efd-f371d53fa739 --><!-- begin field ae361239-cac9-45a2-93f2-9691fc7cca36 --><h5>Manage exudate and odour effectively</h5><ul><li>The recommendations regarding the management of exudate and odour is based on expert opinion in narrative reviews [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Fleck, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Nazarko, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Lazelle-Ali, 2007</a>].</li></ul><h5>Consideration of cosmetic effects</h5><ul><li>The recommendations regarding cosmetic effects are based on expert opinion in a narrative review [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Lazelle-Ali, 2007</a>], and an expert consensus regional primary care guideline, <em>Policy for the management of fungating wounds </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-malignant-skin-ulcer/references/\">Leicester County and Rutland PCT, 2009</a>].</li></ul><!-- end field ae361239-cac9-45a2-93f2-9691fc7cca36 --><!-- end item 78c586f4-bc9e-4e22-8efd-f371d53fa739 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}